How microbial features and functions specific to subspecies and strains contribute to the pathological mechanisms of type 2 diabetes.
Epigenomics AG publishes financial results for fiscal year 2023 – Biotech Investments
EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual Report Epigenomics AG publishes financial results for fiscal year 2023 14.03.2024 / 08:00 CET/CEST The issuer is